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ABSTRACT 
Methicillin resistant Staphylococcus aureus (MRSA) is a hazardous nosocomial pathogen. Therefore the knowledge 
of current trend of MRSA and their antimicrobial profile is necessary. The main goal of the present study to determine 
the current trend of MRSA and their antimicrobial susceptibility pattern in tertiary care hospital Delhi NCR region 
India. 
Clinical specimens were cultured as per conventional microbiological methods. The organisms were identified by 
catalase test,coagulase tube test and mannitol test. Antimicrobial susceptibility test was done as per Kirby-Bauer disc 
diffusion method; the isolates were tested for methicillin resistance by using oxacillin disc. 
A total of 551 isolates were tested as S.aureus out of these 72 isolates were identified as MRSA.Resistant pattern to 
Augmentin and Cefazolin was 100% and resistant to vancomycin was not found. Antimicrobial susceptibility pattern 
varies from region to region but vancomycin still found most effective drug against MRSA in India. 
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INTRODUCTION 
Methicillin resistance in S.aureus was first described in 
1961
1.
 Subsequently more & more incident was reported 
worldwide
2. The worst feature of the MRSA, as it resist 
to many of the antibiotics. Chronic carrier stage among 
health care workers have found greater resistance of the 
strains 
3.
  High  risk  groups  for  MRSA  infection  was 
notice to the patients admitted  in tertiary care centres, 
burn  units  &  ICU
4,5.
  MRSA  strains  have  often  been 
responsible  for  nosocomial  infections  worldwide
6.
  The 
multiple drug resistance makes the therapy more difficult 
&  drug  like  vancomycin  is  quite  expensive.  Proper 
monitoring  &  surveillance  on  MRSA  in  hospitals  is 
essential to control the problem. The reports in India
7-11 
suggests increasing trend of MRSA.  
MATERIALS AND METHODS 
The study was conducted from May 2009 to May 2011 
in  a  tertiary  care  hospital  having  550  beds  facility.  A 
total 18774 clinical specimens were  included in this 
study.  Out  these  190  clinical  specimens  produces 
S.aureus  as  shown  in  (table  1).  On  further  testing  72 
strains  were  identified  as  MRSA.    The  clinical 
specimens included in this study were pus (wound and 
pus swabs), respiratory (sputum, endotracheal secretion, 
bronchial  alveolar  lavage,  throat  swab)  blood,  fluids 
(CSF, pleural fluid, other fluids) and urine specimens. 
The  clinical  specimens  were  cultured  on  blood 
agar,MacConkey  agar  and  mannitol  salt  agar  and 
incubated at 37
0C for 24 hours. The colonies of Gram 
positive cocci in clusters were further confirmed for the 
production  of  free  coagulase  enzyme  and  mannitol 
permentation according to standard methods
12. 
All  the  confirmed  S.aureus  strains  were  subsequently 
tested  for  methicillin  resistance  based  on  Kirby-Bauer 
disc diffusion methods using oxacillin disc (1µg) from 
Hi  Media, India. The Mueller Hinton agar plates with 
lawn culture of the isolates (equivalent to 0.5 McFarland 
standards)  on  which  oxacillin  disc  was  applied  along 
other  drugs  and  incubated  aerobically  at  37
0C  for  24 
hours.  All  the  result  was  interpreted  as  per  CLSI Aslam Mohd et al / IJRAP 2011, 2 (4) 1339-1342 
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13.
  Isolates  with  inhibition  zone  of  <  10  mm 
around  the  oxacillin  disc  was  considered  as  MRSA 
strains.  The  antimicrobials  tested  on  MRSA  were 
Oxacillin,  Cefazolin  Augmentin,  Ciprofloxacin, 
Erythromycin,  Amikacin,  Doxycycline,  Clindamycin, 
Gentamicin  Netilmicin,  Rifampicin,  Tetracycline, 
Tigecycline, Linezolid and Vancomycin. S.aureus ATCC 
29213  was  used  as  control  strain  for  antimicrobial 
susceptibility  testing.  All  antibiotics  discs  and  culture 
media used in this study were from Hi Media, India. 
RESULTS 
A total number of 551 S.aureus strains were tested out 
of  which  72  isolates  were  resistant  to  oxacillin  and 
confirmed  as  MRSA  (13  %).  The  maximum  number 
MRSA were isolated from pus specimens followed by 
respiratory  specimens.  The  prevalence  MRSA  isolated 
from different clinical specimens were; pus specimens 
37(22%),  respiratory  specimens  23(16%),  blood 
specimens  9  (8.5%),  fluids  3  (9.4%)  and  no  MRSA 
isolated  from  urine  specimens  (0%).  Demographically 
analysis  of  data  shows  41(56.9%)  and  31(43.1%)  of 
MRSA  isolates  were  from  males  and  females 
respectively.  The  age  wise  distribution  of  MRSA 
infection  is  shown  in  (Fig  1).  The  current  trend 
antimicrobial  susceptibility  pattern  of  MRSA  is 
shown  in  (Table  2).However  all  the  isolates  were 
sensitive to vancomycin.  
DISCUSSION 
MRSA is recognized as a big problem worldwide. The 
prevalence  of  MRSA  in  hospitals  varies  considerably 
from region to region and among hospitals in the same 
city but the data on the prevalence of MRSA in Indian 
hospitals is limited. The important reservoirs of MRSA in 
hospitals are infected patients and transient nasal carriers 
among  hospital  staff.  In  India,  the  MRSA  infections 
emerged as a big problem in the 1980s and 1990s. The 
MRSA  isolates  are  often  resistant  to  several 
antibiotics.  In  the  last  20  years,  the  appearance  and 
world  wide  spread  of  many  such  isolates  have 
created major therapeutic challenges in many hospitals 
and have led to diversion of considerable resources to 
attempts  at  controlling  their  spread.  Several  studies 
show  that  epidemiology  of  MRSA  is  not  uniform  in 
different parts of India and also has variations with 
time at the same hospitals
14.  
We  have  isolated  72  MRSA  strains  from  different 
clinical specimens submitted to tertiary care hospital 
Delhi  NCR  region  India.  This      amounts      to      a 
prevalence rate of (13.0%) among the patients suffering 
from  S.aureus  infection.  Various  investigators  have 
reported a prevalence rate of MRSA ranging from 26 % 
to 51.6 % in India
15,16. A significant observation in our 
study  was  the  decreased  isolates  of  MRSA      from 
tertiary  care  hospital.  Literature  shows  a  highly 
variable carrier rate ranging from 0% to 29%
17,18,19. All 
the  strains      were      resistant      to      Cefazolin  and 
Augmentin.  Resistance  to  Tigecycline  ,  Linezolid  and 
Vancomycin  was  not found.  In  current  study,  MRSA 
infection was found more in males (56.9%) and less in 
females (43.1%). In the present study it was noted that 
the extreme of the ages were more prone to get MRSA 
infection.  In  age  group  0-10  years  both  sexes  were 
equally affected(11.1%) while in age group 51-60 male 
patients were more predominant (30.6%). 
CONCLUSION 
Antimicrobial  resistance  results  increased  morbidity, 
mortality,  and  costs  of  health  care.  Prevention  of  the 
emergence of MRSA will reduce these adverse effects and 
their  attendant  costs.  Vancomycin  was  found  most 
effective drug against MRSA and can be used as a first-
line treatment for the infection caused by MRSA. This is 
because alternative treatments are limited; development 
of  resistance  to  vancomycin  can  make  treatment  of 
MRSA  infections  increasingly  difficult.  Centers  for 
Disease  Control  and  Prevention  and    World  Health 
Organization  have  recommended  that  there  is  need  to 
find  out  some  newer  alternative  to  get  rid  of  such 
problem.  The  data  presented  in  current  study 
indicated that there was no significant difference of 
MRSA  on  geographical  location  of  the  patients 
attending the hospitals located wide apart. The data on 
prevalence of CA- (MRSA) and HA- (MRSA) was not 
very  clear  so  not  presented.  Elderly  aged  male  were 
preponderance  and  it  was  considered  as  an  important 
demographic findings. 
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Table 1, Identification of S.aureus from different clinical specimens   MRSA 
Specimens  Total Specimens  GPC  Coagulase + S.aureus  Number   Percentage 
Pus  755  168  111  37  22 
Respiratory  1654  144  44  23  16 
Blood  4507  106  18  9  8.5 
Fluids  583  32  11  3  9.4 
Urine  5275  101  6  0  0 
Total  18774  551  190  72  13 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2, Antimicrobials  susceptibility pattern of MRSA(N=72) 
Antibiotics  Disc Content 
Resistant  Sensitive 
Number  %  Number  % 
Oxacillin  1µg  72  100  00  00 
Cefazolin  30µg  72  100  00  00 
Augmentin  20/10µg  72  100  00  00 
Ciprofloxacin  5µg  58  80.6  14  19.4 
Erythromycin  15µg  57  79.2  15  20.8 
Amikacin  30µg  55  76.4  17  23.6 
Doxycycline  30µg  50  69.4  22  30.6 
Clindamycin  2µg  47  65.3  25  34.7 
Gentamicin  10µg  44  61.1  28  38.9 
Netilmicin  30µg  43  59.7  29  40.3 
Rifampicin  5µg  42  58.3  30  41.7 
Tetracycline  30µg  37  51.4  35  48.6 
Tigecycline  30µg  00  00  72  100 
Linezolid  30µg  00  00  72  100 
Vancomycin  30µg  00  00  72  100 Aslam Mohd et al / IJRAP 2011, 2 (4) 1339-1342 
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